Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
- Friday, April 16, 2021, 7:34
- Environment
- Add a comment
THOUSAND OAKS, Calif., April 16, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics (NASDAQ:FPRX), a clinical-stage biotechnology…
About the Author
adminasapcorp has written 41866 stories on this site.